Skip to main content

Advanced Interactive Materials by Design

Objective

Urgent needs for better production technologies arise from current development of new pharmaceutical products like fermantation-based antibodies, recombinant proteins or monoclonal antibodies (MABs). AIMs' goal is integrated design of a new class of interactive materials for the use in the pharmaceutical, chemical and bioindustries as well as development of novel materials composed of functional elements (ligands) interacting with target molecules and support structures for separation applications. The radical innovation in MAB production will be an increase in capacity by a factor of 10 to 50 and a decrease in costs of goods by a factor of 10 to 100. The RTD activities will be grouped into 5 sub-projects: Processing, Functionalisation, Parameter Design, Utilisation of Materials and their Applications to Processes.

A detailed process analysis of existing selective materials for MAB separations and material performance in existing applications will be done in the 1st of three project cycles. This will help to gain quantitative benchmarks and parameters for further development of a design method for selective materials with regard to applications. The 2nd cycle will achieve a paradigm shift from product-based empirical material testing to a material design method based on molecular and process performance prediction knowledge.

RTD activities in various disciplines will be combined with training, result dissemination and exploitation. AIMs will supply the methodology for an outstanding performance and flexibility of material producers, process suppliers and process operators. Pharmaceutical products being currently developed will generate a potential market for a new class of interactive materials that can be tailored to the customers' applications in the process industries. Nine industrial partners, i.e. 4 SMEs, 16 outstanding academic partners and 2 stakeholders will be needed over a period of 4 years, which will on the whole amount to about 160.

Call for proposal

FP6-2002-NMP-1
See other projects for this call

Funding Scheme

IP - Integrated Project

Coordinator

UNIVERSITAET DORTMUND
Address
August Schmidt Strasse 4
Dortmund
Germany

Participants (23)

ABO AKADEMI UNIVERSITY
Finland
Address
Domkyrkotorget 3
Turku
ALMA MATER STUDIORUM - UNIVERSITA DEGLI STUDI DI BOLOGNA
Italy
Address
Via Zamboni 33
Bologna
BAYER TECHNOLOGY SERVICES GMBH
Germany
Address
Bts-pt-cem / B310 Building B
Leverkusen
BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM
Hungary
Address
Muegyetem Rakpart 3-9
Budapest
CENTRALNY INSTYTUT OCHRONY PRACY - PANSTWOWY INSTYTUT BADAWCZY
Poland
Address
Czerniakowska 16
Warsaw
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
France
Address
Rue Michel Ange 3
Paris
DECHEMA GESELLSCHAFT FÜR CHEMISCHE TECHNIK UND BIOTECHNOLOGIE E.V.
Germany
Address
Theodor-heuss Allee 25
Frankfurt Am Main
DSM BIOLOGICS COMPANY BV
Netherlands
Address
Zuiderweg 72
Groningen
ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIER
France
Address
Rue De L'ecole Normale 8
Montpellier
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Switzerland
Address
Raemistrasse 101
Zurich
ELSEVIER LTD
United Kingdom
Address
The Boulevard, Langford Lane
Kidlington
GVS S.P.A.
Italy
Address
Via Roma 50
Zola Predosa
INSTITUTO SUPERIOR TECNICO
Portugal
Address
Avenida Rovisco Pais 1
Lisboa
MERCK KGAA
Germany
Address
Frankfurter Strasse 250
Darmstadt
POLITECHNIKA LODZKA
Poland
Address
Skorupki 6/8
Lodz
POLITECNICO DI MILANO
Italy
Address
Piazza Leonardo Da Vinci 32
Milano
PROMETIC BIOSCIENCES LTD
United Kingdom
Address
Unit 2, Freeport, Ballasalla, Isle Of Man, British Isles
Ballsalla
SARTORIUS STEDIM BIOTECH GMBH
Germany
Address
August-spindler-strasse 11
Goettingen
SLOVENSKA TECHNICKA UNIVERZITA V BRATISLAVE
Slovakia
Address
Vazovova 5
Bratislava
SYNCOM BV
Netherlands
Address
Kadijk 3
Groningen
UNIVERSITEIT TWENTE
Netherlands
Address
Drienerlolaan 5
Enschede
UNIVERSITY OF VIENNA
Austria
Address
Dr. Karl Lueger-ring 1
Wien
XEPTAGEN SPA
Italy
Address
Viale Gramsci 18
Napoli